文献速递神经肿瘤

单次伽玛刀放射外科治疗视路/下丘脑胶质瘤

Single-session Gamma Knife radiosurgery for optic pathway/hypothalamic gliomas.
PubMed 文献 · J Neurosurg · 2016-01-01

本研究回顾了2004年12月至2014年6月间22例接受单次伽玛刀放射外科治疗的视路/下丘脑胶质瘤患者,其中20例随访至少1年。肿瘤控制率为90%,3年无进展生存率为83%,视力稳定12例、改善6例、恶化2例(均伴肿瘤进展)。初步结果表明单次伽玛刀放射外科是安全有效的治疗选择。

要点

  • 单次伽玛刀治疗视路/下丘脑胶质瘤,肿瘤控制率90%,3年无进展生存率83%。
  • 视力稳定12例、改善6例、恶化2例,恶化者均伴肿瘤进展。
  • 随访期间2例患者死亡。

核心结论

  • 初步结果表明,单次伽玛刀放射外科是视路/下丘脑胶质瘤安全有效的治疗选择。

研究设计与样本

  • 回顾性分析2004年12月至2014年6月间22例接受单次伽玛刀放射外科治疗的视路/下丘脑胶质瘤患者,其中20例治疗后随访至少1年。
  • 患者年龄5至43岁(中位16岁),肿瘤体积0.15至18.2 cm³(中位3.1 cm³),处方剂量8至14 Gy(中位11.5 Gy)。

主要发现

  • 平均随访43个月,5例肿瘤仅累及视神经,15例累及视交叉/下丘脑。
  • 随访期间2例患者死亡。
  • 肿瘤缩小12例、稳定6例、进展2例,肿瘤控制率为90%。
  • 视力稳定12例、改善6例、恶化2例,恶化者均伴肿瘤进展。
  • 3年无进展生存率为83%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Because of their critical and central location, it is deemed necessary to fractionate when considering irradiating optic pathway/hypothalamic gliomas. Stereotactic fractionated radiotherapy is considered safer when dealing with gliomas in this location. In this study, the safety and efficacy of single-session stereotactic radiosurgery for optic pathway/hypothalamic gliomas were reviewed. METHODS Between December 2004 and June 2014, 22 patients with optic pathway/hypothalamic gliomas were treated by single-session Gamma Knife radiosurgery. Twenty patients were available for follow-up for a minimum of 1 year after treatment. The patients were 5 to 43 years (median 16 years) of age. The tumor volume was 0.15 to 18.2 cm3 (median 3.1 cm3). The prescription dose ranged from 8 to 14 Gy (median 11.5 Gy). RESULTS The mean follow-up period was 43 months. Five tumors involved the optic nerve only, and 15 tumors involved the chiasm/hypothalamus. Two patients died during the follow-up period. The tumors shrank in 12 cases, remained stable in 6 cases, and progressed in 2 cases, thereby making the tumor control rate 90%. Vision remained stable in 12 cases, improved in 6 cases, and worsened in 2 cases in which there was tumor progression. Progression-free survival was 83% at 3 years. CONCLUSIONS The initial results indicate that single-session Gamma Knife radiosurgery is a safe and effective treatment option for optic pathway/hypothalamic gliomas.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. El-Shehaby AM, Reda WA, Abdel Karim KM, et al. Single-session Gamma Knife radiosurgery for optic pathway/hypothalamic gliomas. J Neurosurg. 2016. PMID: 27903182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。